Article Text

Download PDFPDF

A defective type 1 response to rhinovirus in atopic asthma
  1. N G Papadopoulos1,
  2. L A Stanciu1,2,
  3. A Papi1,
  4. S T Holgate1,
  5. S L Johnston1,2
  1. 1University Medicine, Southampton General Hospital, Southampton SO16 6YD, UK
  2. 2National Lung and Heart Institute, Department of Respiratory Medicine, Faculty of Medicine, Imperial College of Science, Technology & Medicine, London W2 1PG, UK
  1. Correspondence to:
    Professor SL Johnston, Department of Respiratory Medicine, National Heart and Lung Institute, Imperial College of Science, Technology & Medicine, London W2 1PG, UK;


Background: Rhinoviruses (RVs) are the most frequent precipitants of the common cold and asthma exacerbations, but little is known about the immune response to these viruses and its potential implications in the pathogenesis of asthma.

Methods: Peripheral blood mononuclear cells (PBMC) from patients with atopic asthma and normal subjects were exposed to live or inactivated RV preparations. Levels of interferon (IFN)γ and interleukins IL-12, IL-10, IL-4, IL-5 and IL-13 were evaluated in the culture supernatants with specific immunoassays.

Results: Exposure of PBMC to RVs induced the production of IFNγ, IL-12, IL-10, and IL-13. Cells from asthmatic subjects produced significantly lower levels of IFNγ and IL-12 and higher levels of IL-10 than normal subjects. IL-4 was induced only in the asthmatic group, while the IFNγ/IL-4 ratio was more than three times lower in the asthmatic group.

Conclusions: This evidence suggests that the immune response to RVs is not uniquely of a type 1 phenotype, as previously suggested. The type 1 response is defective in atopic asthmatic individuals, with a shift towards a type 2 phenotype in a way similar, but not identical, to their aberrant response to allergens. A defective type 1 immune response to RVs may be implicated in the pathogenesis of virus induced exacerbations of asthma.

  • rhinovirus
  • asthma

Statistics from


    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.